The World in a Grain of Sand: Royalty Pharma

Update: 2023-01-24

Description

KdT Ventures Partners, Mack Healy & Cain McClary take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Royalty Pharma.

Comments

In Channel

The World in a Grain of Sand: BioAge

2024-12-1233:43

The World in a Grain of Sand: CG Oncology

2024-05-2943:43

The World in a Grain of Sand: Verve Therapeutics

2024-02-2241:27

The World in a Grain of Sand: Schrödinger

2023-09-0542:16

The World in a Grain of Sand: Amylyx Pharmaceuticals

2023-04-1934:33

The World in a Grain of Sand: Codiak BioSciences

2023-03-0837:15

The World in a Grain of Sand: Royalty Pharma

2023-01-2439:49

The World in a Grain of Sand: Sana Biotechnology

2022-10-0737:03

The World in a Grain of Sand: Editas

2022-06-3039:05

The World in a Grain of Sand: Century Therapeutics

2022-05-1741:41

The World In A Grain of Sand: Taysha

2022-03-0430:24

The World In A Grain of Sand: Atai

2021-09-2740:19

The World In A Grain of Sand: Recursion Pharmaceuticals

2021-06-2940:25

The World In A Grain of Sand: AbCellera

2021-05-0442:55

00:00

The World in a Grain of Sand: Royalty Pharma

#box-pro-ellipsis-176346173081424{-webkit-line-clamp:2;}The World in a Grain of Sand: Royalty Pharma

The World in a Grain of Sand: Royalty Pharma

KdT Ventures

The World in a Grain of Sand: Royalty Pharma